ALDH marks leukemia stem cell
- PMID: 22500050
- DOI: 10.1182/blood-2012-02-406751
ALDH marks leukemia stem cell
Abstract
In this issue of Blood,Gerber et al use aldehyde dehydrogenase (ALDH) activity to further subdivide the CD34(+)CD38(-) compartment in the bone marrow of acute myeloid leukemia (AML) patients. They identify a unique population with intermediate ALDH activity (ALDH(int)) that contains leukemia stem cells (LSCs). Moreover, persistence of this population after therapy is a marker of clinically significant minimal residual disease.
Comment on
-
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.Blood. 2012 Apr 12;119(15):3571-7. doi: 10.1182/blood-2011-06-364182. Epub 2012 Jan 19. Blood. 2012. PMID: 22262762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials

